Cochrane Abstracts
Teriflunomide for multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Teriflunomide for Multiple Sclerosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436761/all/Teriflunomide_for_multiple_sclerosis_New_search_for_studies_and_content_updated__conclusions_changed_.
Teriflunomide for multiple sclerosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436761/all/Teriflunomide_for_multiple_sclerosis_New_search_for_studies_and_content_updated__conclusions_changed_. Accessed March 28, 2025.
Teriflunomide for multiple sclerosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436761/all/Teriflunomide_for_multiple_sclerosis_New_search_for_studies_and_content_updated__conclusions_changed_
Teriflunomide for Multiple Sclerosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436761/all/Teriflunomide_for_multiple_sclerosis_New_search_for_studies_and_content_updated__conclusions_changed_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Teriflunomide for multiple sclerosis
ID - 436761
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436761/all/Teriflunomide_for_multiple_sclerosis_New_search_for_studies_and_content_updated__conclusions_changed_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
